#accesstomedicines #newmedicines #PharmaNews #MostFavouredNation #MFN #MFNpricingpolicy #WAITIndicator #medicinesaccess #globalpricingreforms #MFNpolicy #pharma #capitalinvestments #clinicaltrials #publicreimbursement #drugapprovals #EMA #EFPIA #EUpolicy #Drugpricing #MarketAccess
zurl.co/zQnRR
zurl.co/zQnRR
European study shows inequality in access to new medicines
Trade organisation EFPIA says disparities in access to new medicines in Europe may be exacerbated by the US's Most-Favoured Nation (MFN) policy.
pharmaphorum.com
May 21, 2026 at 9:08 AM